Phase II Clinical Trial to Evaluate the Safety and Feasibility of Senolytic Therapy in Alzheimer's Disease. CTMS#: 21-0098
Purpose
Category
IRB Number
20210490HU
NCT Number
-
Sponsor
-
Study Contact
Principal Investigator
Valentina Garbarino
Floyd Jones
210-450-3158
jonesfa@uthscsa.edu
Eligibility
Eligible Ages
Eligible Genders
Accepts Healthy Volunteers
No
Inclusion Criteria
Exclusion Criteria
Study Design
Arm Groups